PF-Atlas › Clinical Trials › NCT06634056
Pneumonitis Prevention Protocol Using Pentoxifylline and α-tocopherol In Stage III Non-Small Cell Lung Cancer Patients Undergoing Chemoradiation
Pentoxifylline · Phase 2
Registry ID
NCT06634056
Phase
Phase 2
Status
Recruiting
Drug / intervention
Pentoxifylline
Sponsor
University Health Network, Toronto
Start
2026-06-15
About this trial
Pentoxifylline is evaluated in NCT06634056, a Phase 2 idiopathic pulmonary fibrosis study sponsored by University Health Network, Toronto. Current status: Recruiting.
Explore related
Related trials
Medical disclaimer. This page summarizes public trial data for NCT06634056 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.